MedPath
FDA Approval

Argatroban

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
April 14, 2021
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Argatroban(250 mg in 2.5 mL)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Argatroban

Product Details

NDC Product Code
67457-212
Application Number
ANDA202626
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS
Effective Date
August 29, 2017
Code: IY90U61Z3SClass: ACTIMQuantity: 250 mg in 2.5 mL
SORBITOLInactive
Code: 506T60A25RClass: IACTQuantity: 750 mg in 2.5 mL
ALCOHOLInactive
Code: 3K9958V90MClass: IACTQuantity: 1000 mg in 2.5 mL
WATERInactive
Code: 059QF0KO0RClass: IACT
© Copyright 2025. All Rights Reserved by MedPath